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ABSTRACT 
Chemotherapy management of epidermoid carcinoma of the skin is relatively expensive and 
has toxic effects on vital organs. Phaleria macrocarpa is a medicinal plant that is often used as 
an anti-cancer. This study aims to prove the effectiveness of the Phaleria marcocarpa 
extract, paclitaxel-cisplatin chemotherapy and the combination of both as a neoadjuvant to 
increase caspase-3 expression and apoptotic index in epidermoid carcinoma of the skin in Swiss 
male mice. This study used male mice of the Swiss strain, after induction of epidermoid 
carcinoma cells, 4 group randomization, K (control), P1 (Phaleria macrocarpa 0.0715 mg/ day), 
P2 (paclitaxel 175 mg/m2 and cisplatin 50 mg/m2), P3 (the combination of Phaleria macrocarpa 
and chemotherapy). The caspase-3 expression was examined with immunohistochemical stain 
and the apoptotic index  examination was done by staining the Tunel. The research shows that 
there is an increase in caspase-3 expression; the order of the increase (from the most significant 
to the less significant) is P3, P2, and P1 with significant result (p<0.05) compraed to the control 
group. There is a significant correlation between caspase-3 expression and apoptotic index with 
a very strong positive correlation. It can be concluded that the Phaleria marcocarpa 
extract,  paclitaxel-cisplatin chemotherapy and the combination of both increased the caspase-
3 expression and the apoptotic index of epidermoid carcinoma cell; there was no significant 
differences between P1 and P2 but there was a synergy effect from the administration of P1 and 
P2 combination, and there was significant correlation between the caspase-3 expression and 
apoptotic index with a very strong positive correlation. 
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Epidermoid carcinoma (squamous cell 
carcinoma) is a malignant proliferation of 
epidermal keratinocytes. It is one of the most 
common skin cancers occur after basalioma. The 
incidence is estimated at 25% of all skin 
malignancies. Epidermoid carcinoma is more 
common in white skin than in color and occurs 
more in males than in females, particularly 
people over the age of 40. Incidence of epidermoid 
carcinoma is elevated with increasing 
age.(1)(2) The incidence of metastasis as a whole 
is 2% - 3%. Predisposing factors of epidermoid 
carcinoma include ultraviolet radiation, arsenic, 
hydrocarbon, temperature, chronic radiation, 
scarring, virus.(2)(3) 
According to the National Cancer Institute 
study, the local recurrence rate after primary 
therapy from epidermoid carcinoma reaches 3% - 
23% depending on the location of the 
anatomy. Approximately 58% of local recurrences 
manifested in 1 year, 83% in 3 years, and 95% in 
5 years .(4) According to the American Cancer 
Society, the rate of recurrence of epidermoid 
carcinoma is still high at 2% and 8.9% after 
extensive excision with excision limit at 2cm from 
tumor edge, post radiotherapy 7% - 50% and 20% 
after curettage and electrodesection.(5) 
Modality of epidermoid carcinoma therapy is 
surgery with wide excision and if KGB (+) is 
found, KGB dissection is performed. Primary 
radiation is indicated in an inoperable 
case. Radiation adjuvant is performed on the 
condition: the boundary incision is not free from 
tumor, the incision limit is located near the 
tumor, there is a contamination of the surgical 
field by tumor cells, lymph nodes contain more 
than one metastases, and the diameter of the 
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KGB > 3cm, and there is a high-grade 
malignancy.(2)(3) 
 
Primary chemotherapy is performed in cases 
with indication of distant metastases, inoperable 
or patients who fail to be treated surgically and 
radiotherapy. Currently there is a tendency to 
use neoadjuvant chemotherapy before surgery or 
radiotherapy to reduce tumor volume and 
optimize healing. The chemotherapy commonly 
used is cisplatin, 5-fluorouracil, bleomicin, 
doxorubicin and paclitaxel. The rate for partial 
response is 40%-50% and for the complete 
response is 28%-31% depending on the given 
regimen.(2)(3) 
The management of epidermoid carcinoma of 
the skin is relatively expensive and there are 
often toxic effects that can impair the function of 
some human vital organs.(6) Currently, many 
alternative therapies are developed in the form of 
immunotherapy, namely by modulating the 
immune system against tumors that are expected 
to kill cancer cells spread systemically after the 
local definitive treatment.(7) A number of 
substances which are tested for cancer therapy 
influence the expression factor and or activity 
that regulates apoptosis. In the process of cell 
apoptosis, caspase 3 is the main implementer that 
can be activated through extrinsic and intrinsic 
signal pathways.(8)(9)(10) 
Phaleria macrocarpa (mahkota dewa) is an 
Indonesian medicinal plants that have been 
widely used as an anti-cancer drug plants which 
have been sold on the open market at 5 gram dose 
per day. Phaleria macrocarpa contains alkaloids, 
flavonoids, polyphenols, resins, tannins and 
others substances that are efficacious as 
antihistamines, antioxidants, and medicine for 
rheumatism, diabetes, high blood pressure, and 
cancer (cytotoxic). Empirical evidence of its 
usefulness has been found in many societies, but 
the scientific proof is still very limited and further 
studies are required.(11)(12) 
The purpose of this study is to prove the 
effectiveness of the phaleria marcocarpa extract, 
paclitaxel-cisplatin chemotherapy and the 
combination of both as a neoadjuvant for caspase-
3 expression and apoptotic index of epidermoid 
carcinoma in Swiss mice. 
 
MATERIALS AND METHODS 
Twenty four male Swiss mice aged 3 months 
and weighed 20-30 grams were individually 
stacked and fed with standard feed for one week 
with ad libitum (at the mice’s pleasures) 
system. Epidermoid carcinoma was induced in 
the mice’s skin by clean shaving the hair in 
interscapular area for 1.5 x 1.5 cm. The 
carcinogen used was 9. 12-dimethyl-1.2-
benzanthracene (DMBA) 100 nmol (0.025 mg), 
dissolved in 0.1 ml of acetone reagent per 
mouse. DMBA was applied 2 times per week for 2 
weeks, then continued with topical 12-o-
tetradecanoylphorbol-13-acetate (TPA) 
application in the interscapular region at a dose 
of 1.7 nmol (0.001 mg) in 0.1 ml aceton per mice 
tail 2x per week for 22 weeks. 
The mice which successfully inoculated and 
performed PA biopsy with epidermoid carcinoma 
results, was divided into 4 groups, then they were 
given treatment for 3 weeks. After the treatment 
was completed, the mice in anaesthesia with 
ether and then the mice were exterminated by 
means of cervical dislocation and the tumor 
tissues were taken and processed into histologic 
preparations. Furthermore, Tunel was stained to 
examine the index of apoptosis 
and immunohistochemical staining to observe the 
caspase-3
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RESULTS 
Figure 1. Consolidated research report 
 
 
 
After the treatment, the tumor tissue was taken, 
and histological examination with 
immunohistochemical staining with Caspase 3 
(CPP32) Ab-4 rabbit polyclonal antibody RB-
1197-PO, NeoMarkers was conducted to calculate 
the index of caspase 3 and Tunel staining was 
performed to calculate apoptotic 
index (13,14). With immunohistochemical 
staining on caspase 3, cellular features are called 
positive if there is a dominant brown apoptotic cell 
in the cytoplasm and some in the cell nucleus, as 
well as compared with positive control.(13) Cell 
provides an overview of apoptosis microscopically 
on Tunel staining in the form of the apoptotic cells 
will turn into green fluorescent if observed using 
a fluorescence microscope with magnification of 
400x.(14) Histological examination results are as 
follows 
 
Figure 2. Histological features of caspase 
expression 3 (arrow) 
 
Grafic  1. Box plot of caspase-3 
expression 
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The normality test using the Shapiro-Wilk test 
shows abnormal data. Furthermore, the Kruskal 
Wallis test shows p value <0.05 or significant, 
then to observe the difference between 
groups, Mann Whitney test was performed
 
Table 1. Mann Whitney  caspase 3 expression 
Group P1 P2 P3 
K 0.046* 0.043* 0.043* 
P1 – 0.268 0.046* 
P2  – 0.043* 
note: 
* Significant p<0.05 
 
From table Mann Whitney test, it was found that 
a significant difference (p <0.05) exists between 
the control group (K) and treatment 1 (P1), 
treatment 2 (P2) and treatment 3 (P3), between 
the treatment group 1 (P1) and treatment 3 (P3), 
between treatment 2 (P2) with treatment 3 (P3) 
 
Figure 3. Histologic picture of apoptosis (arrow) 
 
 
 
 
Grafic 2. Box plot of apoptotic index 
 
 
From the data normality test of apoptotic index 
with the Shapiro-Wilk test, it was found that the 
obtained data are not normal. Then, Kruskal 
Wallis test shows p value = 0.022 (p <0.05) or 
significant to determine the difference between 
groups, Mann Whitney test was conducted. 
 
 Table 2. Mann Whitney Test of Apoptotic Index 
Group P1 P2 P3 
K 0.046* 0.043* 0.046* 
P1 – 0.487 0.049* 
P2  – 0.046* 
Note: 
* Significant p<0,05 
 
 
The Mann Whitney test shows a significant 
difference (p <0.05) exist between the control 
group (K) and treatment 1 (P1), treatment 2 (P2) 
and treatment 3 (P3), between the treatment 
group 1(P1) and treatment 3 (P3), between 
treatment 2 (P2) and treatment 3 P3). 
Meanwhile, regarding with the correlation 
between the caspase-3 expression and the 
apoptotic index, the data normality test 
with Shapiro Wilk test shows that caspase 3 
expression has  p value = 0.025 (p <0.05), which 
means that the data distribution is not normal, so 
that for the next test, non-
parametric spearman correlation test was used
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Table 3. Spearman correlation of caspase 3 expression and the apoptotic index 
Variable r P 
Expresi 
Caspase 3 0.961 < 0.001* Indeks 
Apoptosis 
note : 
* Significant p<0,05 
 
The Spearman correlation test table 
shows p value = <0.001 (p <0.05) and the 
value of r = 0.961, so it can be concluded there 
is a significant correlation between caspase 3 
expression and the apoptotic index with a 
very strong positive correlation. 
 
DISCUSSION 
Phaleria macrocarpa is one of Indonesia's 
traditional medicinal plants that have anti-cancer 
effects. However, there is relatively few scientific 
reference in terms of pharmacology and 
phytochemical regarding this plant. Macrocarpa 
Phaleria was used as a medicinal plant for anti-
cancer and anti-microbial. The empirical evidence 
of its usefulness has been found in many societies, 
but the scientific proof is still very limited, so 
further evidences are needed.(11)(12) As an 
attempt to prove the effects of Phaleria 
macrocarpa as anti-cancer drugs particularly on 
the epidermoid carcinoma, this study was 
conducted. This study aimed to prove the effect 
of Phaleria macrocarpa with indicator caspase 3 
expression and apoptotic index of epidermoid 
carcinoma cells in Swiss mice. 
The result shows that there was an increase 
in caspase 3 expression in all treatment groups 
which were given Phaleria macrocarpa 
extract, Paclitaxel-cisplatin chemotherapy, and 
the combination of both. The order of increased 
caspase-3 expression from the most significant 
increase to the least significant increase is the 
group which was given a combination of Phaleria 
macrocarpa extract and chemotherapy paclitaxel-
cisplatin (group P3), followed by the group which 
was given the chemotherapy paclitaxel-
cisplatin (group P2) and the group which was 
given the extract of Phaleria 
macrocarpa (P1). The significant result (p 
<0.05) occurred in all treatment groups compared 
to the control group (K). 
The significant results in the treatment 
group which were given Phaleria macrocarpa 
extract are closely related 
to polyphenols contained in medicinal plants; 
polyphenols are  reported to have the effect of 
inducing apoptosis through TNF-α (extrinsic 
pathway/ extrinsic 
pathway) .(10)(15) Pholyphenol, which 
constitute as active substances, contained 
in Phaleria macrocarpa such as gallic 
acid and flavonoids play a role in inducing 
apoptosis; A study using esophageal cancer 
cells (TE-1) shows that the gallic acid (GA: 
3,4,5-trihydroxybenzoic acid) would increase 
the protein pro apoptosis Bax and will 
decrease Bcl-2 anti-apoptotic protein.(16) 
Meanwhile, flavonoids work by inhibiting the 
activity of DNA topoisomerase I/II, 
modulation of signaling pathways, 
decreasing gene expression of Bcl-2 and Bcl-
XL (anti-apoptotic), increasing gene 
expression of Bax and Bak (pro-apoptotic) as 
well as the activation of endonucleuses.(17) 
Topoisomerase, an enzyme that serves to cut 
the tight winding of DNA is as a result of the 
opening of double strand DNA by enzyme 
helicase, a U-turn and then connect it 
again. The enzyme works on the extension of 
DNA replication. If there is inhibition of 
topoisomerase activity, there will be 
stabilization of the cut topoisomerase-DNA 
complex, resulting in a permanent damage of 
double-stranded DNA which then activates 
p53.(18)(19) Activation of p53 in response to 
DNA damage would stop the cycle of mitosis 
in the G1 phase, so that the cell cannot enter 
S phase when DNA damage is not repaired, 
and if the DNA damage cannot be repaired, 
the p53 will activate protein pro-
apoptotic Bcl-2 Family as Bid, Bax and Tub 
which will subsequently lead to caspase-3 
inactivation which eventually leads to cell 
apoptosis.(20)(21)(22) 
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Bax, Bak, Bcl-2 and Bcl-xl is a Bcl-
2 family proteins. Bax and Tub are 
proapoptotic proteins whereas Bcl-2 and Bcl-
xl are antiapoptotic proteins. Bcl2 attaches to 
the outer membrane of the mitochondria thus 
blocking the release of cytochrome c whereas 
Bcl-xl binds to Apaf-1. Cytochrome c and 
Apaf-1 are required in the process of 
apoptosis through an intrinsic pathway by 
activating caspase-9. The function of survival 
is offset by the cell death function mediated 
by Bax and Bak. Bax may bind to the outer 
membrane of the mitochondria thus inducing 
cytochrome c out of mitochondria while Bak 
may bind with Bcl-xl to release Apaf-1. If the 
expression of Bax or Bak is raised and Bcl-2 
or Bcl-xl is lowered, cell regulation towards 
the cell death by caspese 9 activation will 
lead to caspase-3 inactivation leading to cell 
apoptosis.(15)(16)(21)(22)(23) 
Phaleria macrocarpa extract, Paclitaxel-
cisplatin chemotherapy, and the combination 
of both is also shown to enhance the apoptotic 
index when compared with controls. The 
increase in apoptotic index in the order from 
large to small were seen in the group which 
were given a combination of Phaleria 
macrocarpa extracts and Paclitaxel-
cisplatin chemotherapy (group P3), 
given Paclitaxel-cisplatin chemotherapy 
(group P2) and the group given the 
extract Phaleria macrocarpa (P1). The 
significant result (p <0.05) occurred in all 
treatment groups compared to the control 
group. 
The increase in apoptotic index in the 
treatment group, apart from the gallic 
acid and flavonoids to increase the caspase-3 
expression as described above, gallic 
acid and flavonoids can also stimulate the 
production of interferon-γ (IFN-γ) in a 
population of immunosit, which is very 
important in promoting the activation of CTL 
and NK cells in the immune system of 
immune cells against cancer cells. When CTL 
and NK cell is active and a lot more going on 
the killing of the tumor cells that cause a lot 
of apoptosis of tumor cells.(10)(22) Besides 
the effector function of NK cells to kill cancer 
cells by 
secreting perforin and Granzyme which then 
induce apoptosis of target cells; releasing 
IFN-γ which enhances macrophage 
phagocytosis work; bonding on the target-cell 
death receptor, such as FAS (CD95) or FAS 
ligand (FasL) in opsonized cancer cells that 
causes cancer cell to be programmed as 
apoptosis; As well as breaking/ hydrolyze 
substrate specific proteins including caspase 
causing target cells to undergo 
apoptosis.(10)(15)(16) 
Paclitaxel, in addition to inhibit cell 
proliferation, may also increase apoptosis by 
reducing expression of Bcl-2 and Bcl-xl, and raise 
proapoptosis Bax protein.(24)(25) Meanwhile, in 
addition to inhibit the cell cycle, cisplatin also 
increase apoptosis by inducing P53, P53 will 
induce proapoptosis Bax protein that will 
ultimately lead to cell apoptosis. Therefore, a 
synergistic effect between the extract Phaleria 
macrocarpa and Paclitaxel-
cisplatin chemotherapy is 
obtained.(16)(19)(26)(27) 
The result of correlation test which was 
performed to analyze the correlation between the 
caspas-3 expression and the apoptotic index 
using Spearman's test shows a significant 
correlation with p = <0.001 (p <0.05) and the value 
of r = 0.961, so it can be concluded that there is a 
significant correlation between caspase-3 
expression and apoptotic index with a very strong 
positive correlation. This is in accordance with the 
three mechanisms of apoptosis: 
1. Extrinsic pathway where there is a death 
receptor activation (DR) on the surface of the cell 
membrane by ligands which then activates 
caspase 8 and eventually cause the activation of 
caspase 3. 
2. intrinsic pathway where there is cellular 
stress (oxidative stress, radiation, cytotoxic drugs) 
which will cause the mitochondria to 
synthesize cytocrom c binding to Apaf-1 and pro-
caspase 9 forms apoptosome which will cause the 
activation of caspase 9 and in the end causing 
caspase 3 to be activated. Intrinsic pathway can 
also be activated by caspase 8) through protein 
breakdown Bid. 
3. Granzime B pathways that are sensitive to the 
target cell .(15)(21)(28)
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Figure 4. Apoptosis path (26) 
                                                                    
                                               
 
 
 
 
CONCLUSION 
Based on this study, it can be concluded that 
Phaleria marcocarpa 
extract, chemotherapy paclitaxel 
cisplatin and the combination of both 
increased caspase-3 expression and the 
apoptotic index of epidermoid carcinoma cell; 
it was not found significant differences 
between P1 and P2; a synergy effect was 
obtained from the administration of the 
combination of P1 and P2; there is a 
significant correlation between caspase-3 
expression and apoptotic index with a very 
strong positive correlation. 
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